After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?

IF 1.2 Q4 RHEUMATOLOGY

Reumatismo Pub Date : 2025-06-10 Epub Date: 2025-03-03 DOI:10.4081/reumatismo.2025.1823

Ciro Manzo, Marco Isetta

引用次数: 0

Abstract

Dear Editor, The number of cases of cancer patients diagnosed as having immune checkpoint inhibitor-mediated polymyalgia rheumatica is increasing...

查看原文本刊更多论文

在什么时间间隔后，我们有理由诊断免疫检查点抑制剂介导的风湿性多肌痛？

亲爱的编辑，在已发表的报告中，被诊断为免疫检查点抑制剂介导的风湿性多肌痛的癌症患者的数量一直在稳步上升。然而，缺乏有效的量表或算法仍然是诊断这种病理性实体的相关方法学限制。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Reumatismo RHEUMATOLOGY-

CiteScore

2.10

自引率

7.10%

发文量

审稿时长

10 weeks

期刊介绍： Reumatismo is the official Journal of the Italian Society of Rheumatology (SIR). It publishes Abstracts and Proceedings of Italian Congresses and original papers concerning rheumatology. Reumatismo is published quarterly and is sent free of charge to the Members of the SIR who regularly pay the annual fee. Those who are not Members of the SIR as well as Corporations and Institutions may also subscribe to the Journal.